Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
73 Leser
Artikel bewerten:
(0)

Hutchinson Center Researcher Receives First National Institutes of Health Director's Early Independence Award

SEATTLE, Sept. 30, 2011 /PRNewswire/ -- Carissa Perez Olsen, Ph.D., a Weintraub Scholar in the Basic Sciences Division of Fred Hutchinson Cancer Research Center, is the recipient of the National Institutes of Health Director's Early Independence Award, announced today. She is among the first group of 10 junior U.S. investigators to receive the honor. The NIH plans to commit approximately $19.3 million to support their research over a five-year period; Olsen will receive $1.25 million to support her research into the mechanisms of cancer, aging-related diseases and natural aging.

"The award of this grant is a tribute to Carissa's success and recognizes her enormous potential as an independent researcher. The grant will jump-start her career and allow her to go straight from graduate student to faculty and bypass the usual postdoctoral fellowship stage," said Jonathan Cooper, Ph.D., director of the Hutchinson Center's Basic Sciences Division. "Her laboratory will be a valuable addition to our group of researchers who explore physiology, metabolism and aging."

The Early Independence Awards program effectively allows awardees to leapfrog over the traditional postdoctoral training period to capitalize in the creativity, confidence and energy of young scientists.

"The Early Independence Award enables outstanding investigators to establish their independent research careers as soon as possible," said NIH Director Francis S. Collins, M.D., Ph.D. "These Early Independence Award recipients have demonstrated exceptional scientific creativity and productivity."

By studying a model organism called C. elegans - a tiny roundworm - Olsen's research focuses on the membranes that are essential for all cellular life. Membranes are made of phospholipids, cholesterol and membrane proteins that together form a dynamic barrier that is vital to cellular survival. "The properties of a membrane can be dramatically affected by altering the composition of these components. Therefore, it is important to understand how proper composition of phospholipids is maintained in cellular membranes, because even small changes can impact the ability of the membrane to function properly," Olsen said. Altered membrane composition has been observed in many disease states, including cancer, aging-related diseases and natural aging.

Olsen received her doctoral degree in June from the joint Hutchinson Center/University of Washington Molecular and Cellular Biology Program and she received her undergraduate degree at Cornell University in Ithaca, N.Y. She is a native of Oak Ridge, N.J.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

"This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com."

Media Contacts:
Kristen Lidke Woodward
kwoodwar@fhcrc.org
206-667-5095

SOURCE Fred Hutchinson Cancer Research Center

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.